NDC 66302-206

TYVASO

Treprostinil

TYVASO is a Oral Inhalant in the Human Prescription Drug category. It is labeled and distributed by United Therapeutics Corporation. The primary component is Treprostinil.

Product ID66302-206_1cd808bf-a8ed-44bb-b7e3-6872c9afa6c6
NDC66302-206
Product TypeHuman Prescription Drug
Proprietary NameTYVASO
Generic NameTreprostinil
Dosage FormInhalant
Route of AdministrationORAL
Marketing Start Date2009-08-14
Marketing CategoryNDA / NDA
Application NumberNDA022387
Labeler NameUnited Therapeutics Corporation
Substance NameTREPROSTINIL
Active Ingredient Strength2 mg/2.9mL
Pharm ClassesProstacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 66302-206-01

1 BOX in 1 KIT (66302-206-01) > 28 AMPULE in 1 BOX > 2.9 mL in 1 AMPULE
Marketing Start Date2009-08-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66302-206-03 [66302020603]

TYVASO INHALANT
Marketing CategoryNDA
Application NumberNDA022387
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-08-14

NDC 66302-206-02 [66302020602]

TYVASO INHALANT
Marketing CategoryNDA
Application NumberNDA022387
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-08-14

NDC 66302-206-04 [66302020604]

TYVASO INHALANT
Marketing CategoryNDA
Application NumberNDA022387
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-08-14

NDC 66302-206-01 [66302020601]

TYVASO INHALANT
Marketing CategoryNDA
Application NumberNDA022387
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-08-14

Drug Details

Active Ingredients

IngredientStrength
TREPROSTINIL1.74 mg/2.9mL

OpenFDA Data

SPL SET ID:cbc31ab1-a80f-4b50-a3b1-39910b0fb609
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 857799
  • 857795
  • Pharmacological Class

    • Prostacycline Vasodilator [EPC]
    • Prostaglandins I [CS]
    • Vasodilation [PE]

    NDC Crossover Matching brand name "TYVASO" or generic name "Treprostinil"

    NDCBrand NameGeneric Name
    66302-206TYVASOTYVASO
    66302-101Remodulintreprostinil
    66302-102Remodulintreprostinil
    0703-0666TreprostinilTreprostinil
    0703-0676TreprostinilTreprostinil
    0703-0686TreprostinilTreprostinil
    0703-0696TreprostinilTreprostinil
    0781-3420Treprostiniltreprostinil
    0781-3425Treprostiniltreprostinil
    0781-3427Treprostiniltreprostinil
    0781-3430Treprostiniltreprostinil
    42023-206TreprostinilTreprostinil
    42023-207TreprostinilTreprostinil
    42023-208TreprostinilTreprostinil
    42023-209TreprostinilTreprostinil
    62332-514TreprostinilTreprostinil
    62332-515TreprostinilTreprostinil
    62332-516TreprostinilTreprostinil
    62332-517TreprostinilTreprostinil

    Trademark Results [TYVASO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TYVASO
    TYVASO
    77425786 3709561 Live/Registered
    UNITED THERAPEUTICS CORPORATION
    2008-03-19

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.